The worst is yet to come: Contact tracing, immunity cards and mass testing
Share
No one is safe. No one is immune. No one gets spared the anguish, fear and heartache of living under the shadow of an authoritarian police state.
Search Results for U.S. House
Share
Rare Book School at the University of Virginia releases Presswork: A Documentary
Share
Presswork: A Documentary describes the scope of RBS’s “Presswork” program—charting how the project began with RBS’s commissioning of a wooden rolling press.
Morgan Griffith: Don’t redefine ‘flattening the curve’
Share
To wait to reopen the economy until the virus was eliminated, which was not the original goal, would be ruinous to the livelihoods and well-being of many.
Earth Talk: Does gaming contribute to climate change?
Share
The connection between video gaming and global warming is mostly about energy use.
Climate, energy news roundup: May 9
Share
The Climate Action Alliance of the Valley (CAAV) is a non-profit, grassroots group of volunteers in the Central Shenandoah Valley.
USDA approves program to help Virginia children gain access to food
Share
The USDA has approved funding for Virginia to operate the Pandemic Electronic Benefit Transfer.
Spanberger to IRS: Resume customer service operations via telework
Share
Rep. Abigail Spanberger is leading an effort calling on the IRS to provide additional information on the status of economic impact payments to taxpayers in Central Virginia and across the country.
McEachin pushes inclusion of water shut-off prohibition in future COVID-19 stimulus
Share
Congressman A. Donald McEachin is requesting that any future COVID-19 stimulus legislation considered include a prohibition on water shutoffs as a condition for county governments to receive federal funding.
Warner, DelBene propose federal funds to states to modernize unemployment benefits technology
Share
U.S. Sen. Mark Warner (D-VA) and U.S. Rep. Suzan DelBene (D-WA) released the text of draft bicameral legislation to establish an emergency portable benefits fund for states.
FDA reversing course on fast-track approvals for COVID-19 antibody tests
Share
The FDA is walking back a policy that allowed many companies to market unvalidated and unreliable COVID-19 antibody tests.
